We are live on ! Find out more
AZNH

AstraZeneca
AZNH

Delisted

AZNH was delisted on the 29th of January, 2026.

Back to rankings

2 hedge funds and large institutions have $1.55M invested in AstraZeneca in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

91.87% more ownership

Funds ownership: 0% → 91.87% (+92%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.67M
2
UBS Group
UBS Group
Switzerland
+$4.88K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$1.54M +$1.67M +36,640 New
UBS Group
2
UBS Group
Switzerland
$4.5K +$4.88K +107 New

AZNH Hedge Fund Activity: Q4 2024 in Review

2 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZNH) for Q4 2024, worth a combined $1.55M.

Buyers outnumbered sellers: 2 funds opened new AZNH positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.67M.

  • 2 institutional investors held AstraZeneca (AZNH) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $1.55M of AstraZeneca stock for Q4 2024.
  • 2 funds opened new AstraZeneca positions in Q4 2024 and 0 closed out, a net change of +2 holders.
  • The largest AstraZeneca buyer in Q4 2024 was Citadel Advisors, an estimated $1.67M added.

Based on aggregated 13F filings for Q4 2024.